Pharmacology of thromboxane synthetase inhibitors.
D000818:Animals; D001241:Aspirin / Q000494:pharmacology; D001792:Blood Platelets / Q000201:enzymology; D004285:Dogs; D011464:Epoprostenol / Q000494:pharmacology; D006168:Guinea Pigs; D006801:Humans; D007052:Ibuprofen / Q000494:pharmacology; D007213:Indomethacin / Q000494:pharmacology; D007700:Kinetics; D008168:Lung / Q000201:enzymology; D008689:Methacrylates / Q000494:pharmacology; D008861:Microsomes / Q000201:enzymology*; D010088:Oxidoreductases / Q000037:antagonists & inhibitors*; D013930:Thromboxane-A Synthase / Q000037:antagonists & inhibitors*
D008689:Methacrylates; C031517:2-methyl-3-(4-(3-pyridinylmethyl)phenyl)-2-propenoic acid; D011464:Epoprostenol; D010088:Oxidoreductases; D013930:Thromboxane-A Synthase; D001241:Aspirin; D007052:Ibuprofen; D007213:Indomethacin